Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -453,897 | -349,548 | -209,068 | -142,803 | -366,286 |
| Depreciation Amortization | -9,053 | -6,544 | -4,575 | -1,939 | -57 |
| Accounts receivable | 5,590 | 79,850 | 70,519 | 92,638 | -72,059 |
| Accounts payable and accrued liabilities | 15,990 | -19,215 | -17,064 | -13,869 | 8,119 |
| Other Working Capital | -209,390 | -148,005 | -139,546 | -45,520 | -77,260 |
| Other Operating Activity | 149,813 | 58,654 | 29,916 | -38,445 | 200,030 |
| Operating Cash Flow | $-500,947 | $-384,808 | $-269,818 | $-149,938 | $-307,513 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -83,686 | -179,943 | 164,546 | 81,835 | -186,138 |
| PPE Investments | -45,280 | -19,783 | -10,727 | -4,493 | -23,805 |
| Purchase Sale Intangibles | -5,061 | -2,514 | -15,264 | -1,237 | -4,184 |
| Other Investing Activity | -5,061 | -2,514 | -15,264 | -1,237 | -4,184 |
| Investing Cash Flow | $-134,027 | $-202,240 | $138,555 | $76,105 | $-214,127 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | -78 | N/A | 575,000 |
| Debt Repayment | -44,671 | -126 | N/A | -39 | -502,278 |
| Common Stock Issued | 522,729 | 522,300 | 26,205 | 23,609 | 49,442 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 521,918 |
| Financing Cash Flow | $478,058 | $522,174 | $26,127 | $23,570 | $644,082 |
| Exchange Rate Effect | -273 | 213 | -137 | -114 | 352 |
| Beginning Cash Position | 399,266 | 399,266 | 399,266 | 399,266 | 276,472 |
| End Cash Position | 242,077 | 334,605 | 293,993 | 348,889 | 399,266 |
| Net Cash Flow | $-157,189 | $-64,661 | $-105,273 | $-50,377 | $122,794 |
| Free Cash Flow | |||||
| Operating Cash Flow | -500,947 | -384,808 | -269,818 | -149,938 | -307,513 |
| Capital Expenditure | -45,280 | -19,783 | -10,727 | -4,493 | -23,805 |
| Free Cash Flow | -546,227 | -404,591 | -280,545 | -154,431 | -331,318 |